Art
J-GLOBAL ID:202302260811816767   Reference number:23A0656172

Graphene Oxide and Graphene Quantum Dots as Delivery Systems of Cationic Porphyrins: Photo-Antiproliferative Activity Evaluation towards T24 Human Bladder Cancer Cells

カチオン性ポルフィリンのデリバリー系としての酸化グラフェンとグラフェン量子ドット:T24ヒト膀胱癌細胞に対する光抗増殖活性評価【JST・京大機械翻訳】
Author (14):
Material:
Volume: 13  Issue:Page: 1512  Publication year: 2021 
JST Material Number: U7258A  ISSN: 1999-4923  Document type: Article
Article type: 原著論文  Country of issue: Switzerland (CHE)  Language: ENGLISH (EN)
Abstract/Point:
Abstract/Point
Japanese summary of the article(about several hundred characters).
All summary is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
The development of new photody...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=23A0656172&from=J-GLOBAL&jstjournalNo=U7258A") }}
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.

Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
, 【Automatic Indexing@JST】
JST classification (2):
JST classification
Category name(code) classified by JST.
Eight or more-membered heterocyclic compounds  ,  Basic research of antitumor(=antineoplastic)drugs 
Reference (47):
  • Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2021, 71, 209-249.
  • Lamm, D.L.; Morales, A. A BCG Success Story: From Prevention of Tuberculosis to Optimal Bladder Cancer Treatment. Vaccine 2021, S0264-410X(21)01046-X.
  • Cambier, S.; Sylvester, R.J.; Collette, L.; Gontero, P.; Brausi, M.A.; van Andel, G.; Kirkels, W.J.; Silva, F.C.D.; Oosterlinck, W.; Prescott, S.; et al. EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-Specific and Overall Survival in Non-Muscle-Invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. Eur. Urol. 2016, 69, 60-69.
  • Zimmermann, K.; Mostafaei, H.; Heidenreich, A.; Schmelz, H.U.; Shariat, S.F.; Mori, K. Health-Related Quality of Life in Bladder Cancer Patients: General and Cancer-Specific Instruments. Part 1. Curr. Opin. Urol. 2021, 31, 297-303.
  • Inoue, K. 5-Aminolevulinic Acid-Mediated Photodynamic Therapy for Bladder Cancer. Int. J. Urol. 2017, 24, 97-101.
more...

Return to Previous Page